TURKCELL ILETISIM HIZMETLERI A.S. - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing, dated March 28, 2025, reports on a material event for TURKCELL ILETISIM HIZMETLERI A.S., a foreign private issuer. The filing discloses the execution of a long-term loan agreement with China Development Bank (CDB) on March 27, 2025.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data. The primary financial metric disclosed is the debt instrument details:
- Loan Amount: RMB 1.23 billion (approximately EUR 152 million).
- Total Credit Package: RMB 2.46 billion (this loan represents the second tranche).
- Lender: China Development Bank (CDB).
- Repayment Structure: Installments ranging from 1.25% to 12.5% of the principal, with the first payment due on April 10, 2028, and the final payment due on the 10th anniversary of the Financial Closing Date.
Material Changes
The signing of this agreement represents a material change in the company's debt profile, adding RMB 1.23 billion to its liabilities. This follows previous announcements regarding the credit package made on May 29, 2024, September 30, 2024, and November 13, 2024.
Outlook, Risks, and Management Commentary
Management has secured long-term financing to support its operations or strategic initiatives, as indicated by the multi-year repayment schedule extending to 2034. The filing does not explicitly detail specific risks, contingencies, or unusual items beyond the standard obligations of the loan agreement. The "Financial Closing Date" is defined as the date CDB confirms receipt of all conditions precedent.
Investor Verification Checklist
- Verify the exact "Financial Closing Date" to determine the precise final repayment deadline.
- Confirm the interest rate and currency of the loan (principal is in RMB, repayment terms do not explicitly state the interest rate in this text).
- Review the specific "conditions precedent" required by CDB for the loan to become effective.
- Assess the impact of the RMB 1.23 billion liability on the company's total debt-to-equity ratio and liquidity position.
- Check for any covenants or restrictions associated with the CDB loan agreement not detailed in this summary.